Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Cell Death Dis ; 5: e1392, 2014 Aug 28.
Article in English | MEDLINE | ID: mdl-25165878

ABSTRACT

Normal placentation relies on an efficient maternal adaptation to pregnancy. Within the decidua, natural killer (NK) cells and dendritic cells (DC) have a critical role in modulating angiogenesis and decidualization associated with pregnancy. However, the contribution of these immune cells to the placentation process and subsequently fetal development remains largely elusive. Using two different mouse models, we here show that optimal placentation and fetal development is sensitive to disturbances in NK cell relative abundance at the fetal-maternal interface. Depletion of NK cells during early gestation compromises the placentation process by causing alteration in placental function and structure. Embryos derived from NK-depleted dams suffer from intrauterine growth restriction (IUGR), a phenomenon that continued to be evident in the offspring on post-natal day 4. Further, we demonstrate that IUGR was accompanied by an overall reduction of global DNA methylation levels and epigenetic changes in the methylation of specific hepatic gene promoters. Thus, temporary changes within the NK cell pool during early gestation influence placental development and function, subsequently affecting hepatic gene methylation and fetal metabolism.


Subject(s)
Dendritic Cells/cytology , Epigenesis, Genetic , Killer Cells, Natural/cytology , Animals , DNA Methylation , Dendritic Cells/immunology , Female , Fetal Growth Retardation , Heparin-binding EGF-like Growth Factor/genetics , Heparin-binding EGF-like Growth Factor/metabolism , Killer Cells, Natural/immunology , Mice , Mice, Inbred C57BL , Placenta/pathology , Placentation , Pregnancy , Uterus/pathology
2.
Clin Exp Allergy ; 43(3): 353-64, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23414544

ABSTRACT

BACKGROUND: Oral supplementation with probiotic bacteria can protect against the development of allergic and inflammatory diseases. OBJECTIVE: The aim of this study was to investigate potential immunomodulatory and allergy-protective effects of processed Lactobacillus rhamnosus GG (LGG)-derived supernatants early in life in neonatal mice. METHODS: In vitro, RAW264.7 mouse macrophages were stimulated with viable LGG, LGG-derived supernatants, prepared from different growth phases, and different size fractions thereof, and pro- and anti-inflammatory cytokine production was analysed. Supernatant fractions were also treated with protease, DNAse or carbohydrate-digesting enzymes to define the nature of immunomodulatory components. In vivo, neonatal Balb/c mice were orally supplemented with differentially processed LGG supernatants. Starting at 4 weeks of age, a protocol of ovalbumin-induced acute allergic airway inflammation was applied and protective effects of processed LGG supernatants were assessed. RESULTS: Incubation of RAW264.7 cells with LGG-derived supernatants significantly increased TNFα and IL-10 production. These effects were not restricted to a particular molecular size fraction. Treatment with protease, but not with DNAse or carbohydrate-digesting enzymes, completely abolished the immunomodulatory activities. Incubation of TLR/NOD-transfected cells with LGG-derived supernatants revealed that recognition and signalling of bioactive components is mediated by TLR2 and NOD2. In vivo supplementation of newborn mice with processed LGG-derived supernatants resulted in pronounced protective effects on the allergic inflammatory response as reflected by reduced eosinophil numbers, modified T helper cell cytokine production, significantly less lung inflammation and reduced goblet cell numbers in comparison with sham-treated controls. CONCLUSION: LGG-derived supernatants exert immunomodulatory activities, and neonatal administration of specifically processed supernatants may provide an alternative to viable probiotics in reducing allergic inflammatory responses.


Subject(s)
Culture Media, Conditioned/pharmacology , Hypersensitivity/immunology , Immunologic Factors/pharmacology , Inflammation/immunology , Lacticaseibacillus rhamnosus/immunology , Probiotics , Animals , Cell Line , Female , Humans , Hypersensitivity/metabolism , Hypersensitivity/therapy , Inflammation/metabolism , Inflammation/therapy , Lacticaseibacillus rhamnosus/chemistry , Lacticaseibacillus rhamnosus/growth & development , Mice , Nod2 Signaling Adaptor Protein/metabolism , Toll-Like Receptor 2/metabolism
3.
Eur Respir J ; 39(2): 429-38, 2012 Feb.
Article in English | MEDLINE | ID: mdl-21828027

ABSTRACT

Development of allergic asthma is a complex process involving immune, neuronal and tissue cells. In the lung, Clara cells represent a major part of the "immunomodulatory barrier" of the airway epithelium. To understand the contribution of these cells to the inflammatory outcome of asthma, disease development was assessed using an adjuvant-free ovalbumin model. Mice were sensitised with subcutaneous injections of 10 µg endotoxin-free ovalbumin in conjunction with naphthalene-induced Clara cell depletion. Clara epithelial cell depletion in the lung strongly reduced eosinophil influx, which correlated with decreased eotaxin levels and, moreover, diminished the T-helper cell type 2 inflammatory response, including interleukin (IL)-4, IL-5 and IL-13. In contrast, airway hyperresponsiveness was increased. Further investigation revealed Clara cells as the principal source of eotaxin in the lung. These findings are the first to show that Clara airway epithelial cells substantially contribute to the infiltration of eotaxin-responsive CCR3+ immune cells and augment the allergic immune response in the lung. The present study identifies Clara cells as a potential therapeutic target in inflammatory lung diseases such as allergic asthma.


Subject(s)
Asthma/immunology , Eosinophils/immunology , Hypersensitivity/immunology , Respiratory Mucosa/immunology , Allergens/immunology , Allergens/pharmacology , Animals , Asthma/pathology , Chemokine CCL11/immunology , Chemokine CCL11/metabolism , Cytokines/immunology , Cytokines/metabolism , Eosinophils/pathology , Female , Hypersensitivity/pathology , Mice , Mice, Inbred BALB C , Naphthalenes/immunology , Naphthalenes/pharmacology , Ovalbumin/immunology , Ovalbumin/pharmacology , Receptors, CCR3/metabolism , Respiratory Mucosa/pathology , T-Lymphocytes/immunology , T-Lymphocytes/metabolism , T-Lymphocytes/pathology
4.
Eur Respir J ; 36(1): 105-15, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20075049

ABSTRACT

The lung epithelia facilitate wound closure by secretion of various cytokines and growth factors. Nerve growth factor (NGF) has been well described in airway inflammation; however, its likely role in lung repair has not been examined thus far. To investigate the repair function of NGF, experiments were performed in vitro using cultured alveolar epithelial cells and in vivo using a naphthalene-induced model of Clara epithelial cell injury. Both in vitro and in vivo experiments revealed airway epithelial cell proliferation following injury to be dependent on NGF and the expression of its receptor, tropomyosin-receptor-kinase A. Additionally, NGF also augmented in vitro migration of alveolar type II cells. In vivo, transgenic mice over-expressing NGF in Clara cells (NGFtg) did not reveal any proliferation or alteration in Clara cell phenotype. However, following Clara cell specific injury, proliferation was increased in NGFtg and impaired upon inhibition of NGF. Furthermore, NGF also promoted the expression of collagen I and fibronectin in vitro and in vivo during repair, where significantly higher levels were measured in re-epithelialising NGFtg mice. Our study demonstrates that NGF promotes the proliferation of lung epithelium in vitro and the renewal of Clara cells following lung injury in vivo.


Subject(s)
Bronchioles/metabolism , Cell Proliferation , Lung Injury/metabolism , Nerve Growth Factor/metabolism , Animals , Cell Movement , Cells, Cultured , Collagen Type I/analysis , Female , Fibronectins/analysis , Lung Injury/chemically induced , Mice , Mice, Inbred C57BL , Mice, Transgenic , Naphthalenes/toxicity , Protein Kinases/metabolism , Receptors, Nerve Growth Factor/metabolism
5.
Clin Exp Allergy ; 39(8): 1246-54, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19438585

ABSTRACT

INTRODUCTION: The most widely used protocol for the induction of experimental allergic airway inflammation in mice involves sensitization by intraperitoneal (i.p.) injections of the antigen ovalbumin (OVA) used in conjunction with the adjuvant aluminium hydroxide (alum). Although adjuvants are frequently used, there are questions regarding the necessity of alum for murine asthma studies due to the non-physiological nature of this chemical. OBJECTIVE: The objective of this study was to compare experimental asthma phenotypes between adjuvant and adjuvant-free protocols of murine allergic airway inflammation in an attempt to develop a standardized alternative to adjuvant use. METHOD: An adjuvant-free OVA model of experimental asthma was investigated in BALB/c mice using i.p. or subcutaneous (s.c.) sensitization routes. For the s.c. sensitization, beta-galactosidase (beta-gal) was also tested as an antigen. In addition, OVA adjuvant and adjuvant-free sensitization protocols were compared in BALB/c and C57BL/6 mice. Open-field testing was performed to assess the effect of alum on mouse behaviour. RESULTS: Comparison of adjuvant vs. adjuvant-free and i.p. vs. s.c. protocols revealed that both adjuvant use and route of antigen application significantly influenced OVA-specific antibody production. Comparison of adjuvant and adjuvant-free protocols in this study clearly demonstrated the non-requirement of alum for the induction of acute allergic airway inflammation, as both protocols induce a similar disease phenotype. BALB/c mice were significantly more susceptible than C57BL/6 mice to sensitization. Using the improved s.c. adjuvant-free protocol, it was demonstrated that alternative antigens such as beta-gal can also be utilized. Behavioural studies indicated severe distress in mice treated with alum. CONCLUSION: The OVA s.c. adjuvant-free protocol used in this study generates a phenotype comparable to the benchmark adjuvant protocol widely used in the literature. The adjuvant-free alternative avoids the added complication of non-physiological adjuvants that may interfere with asthma treatment or prevention strategies.


Subject(s)
Adjuvants, Immunologic/administration & dosage , Allergens/administration & dosage , Aluminum Hydroxide/administration & dosage , Asthma/physiopathology , Disease Models, Animal , Ovalbumin/administration & dosage , Adjuvants, Immunologic/chemistry , Aluminum Hydroxide/adverse effects , Aluminum Hydroxide/chemistry , Animals , Bronchial Hyperreactivity/physiopathology , Female , Injections, Intraperitoneal , Injections, Subcutaneous , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Phenotype , Sensitivity and Specificity , Skin Tests , beta-Galactosidase/administration & dosage
6.
Vet Immunol Immunopathol ; 87(3-4): 439-41, 2002 Sep 10.
Article in English | MEDLINE | ID: mdl-12072270

ABSTRACT

The T cell, which plays an integral role in the coordination of the immune system, has a heterodimer receptor (TCR) that can exist in one of the two forms: alpha/beta or gamma/delta. Cells displaying the gamma/delta TCR comprise less than 5% of T cell populations in humans and mice. In the bovine system, however, gamma/delta populations can reach as high as 60%. Differences in T cell populations make the bovine system an excellent candidate for genomic TCR sequencing and multi-species comparisons. In an effort to characterize the bovine TCR loci, a genomic library was screened for the beta TCR gene. A shotgun sequencing library was constructed and preliminary analysis demonstrates that the organization of the bovine TCR beta constant regions is different from both humans and mice. The bovine beta locus appears to have a third constant region. Overall, the genomic characterization of the bovine TCR genes will provide insight into the evolution of T cell receptor.


Subject(s)
Cattle/immunology , Chromosome Mapping , Animals , Cattle/genetics , Genes, T-Cell Receptor beta
8.
J Trauma Stress ; 14(4): 741-56, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11776421

ABSTRACT

In unstructured interviews, 24 Mexicans described survivors' responses to disasters in Guadalajara, Jalisco (n = 9), Homestead, Florida (n = 6), and Puerto Angel, Oaxaca (n = 9). This analysis assessed the extent to which symptom descriptions corresponded to the 17 criterion symptoms of PTSD. Nineteen participants (79%) mentioned from 1 to 9 criterion symptoms. Event-related distress, hypervigilance, recurrent recollections, and avoiding reminders were described most often. Only 3 criterion symptoms were never described. Twenty participants (83%) provided 109 separate expressions that could not be classified specifically as criterion symptoms. These phrases were sorted by 9 independent Mexican volunteers and cluster analyzed. Clusters composed of ataques de nervios, depression, lasting trauma, and somatic complaints provided the best description of the data.


Subject(s)
Disasters , Stress Disorders, Post-Traumatic/epidemiology , Stress Disorders, Post-Traumatic/psychology , Survivors/psychology , Adult , Cross-Cultural Comparison , Culture , Female , Florida/epidemiology , Humans , Male , Mexico/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...